Skip Navigation Links
 تاریخ های مهم 
 Pre Registered 
 برنامه همایش 
 Personal page 
                             دومین ويژه نامه همايش بهاره چشم پزشكي منتشر شد        شب بهاری چشم پزشکی با رحیم شهریاری       دومین همایش بهاره چشم پزشکی
Skip Navigation Links
        مکان برگزاری
        تاریخ های مهم
        ثبت نام
        ثبت نام شدگان
        برنامه همایش
        صفحه شخصی
        جستجوی سخنران
مقاله Abstract

Title: Photocoagulation of peripheral ischemic retina accelerates the resolution of macular edema in central retinal vein occlusion. A randomized double-masked controlled clinical trial
Author(s): Nourinia Ramin, Emamverdi mehdi, Amizadeh Yashar, Ramezani Alireza, Khorshidifar Milad, Behnaz Nazanin
Presentation Type: Poster
Subject: Retina and Retinal Cell Biology
Presenting Author:
Name: Yashar Amizadeh
Affiliation :(optional) Shahid Beheshti University of Medical Sciences
E mail:
Phone: 04133317571
Mobile: 09144024927

To investigate the additional beneficial effect of peripheral ischemic retinal photocoagulation besides intravitreal bevacizumab in macular edema due to ischemic central retinal vein occlusion (CRVO).


A randomized double-masked controlled clinical trial was designed to evaluate the efficacy of Intravitreal bevacizumab (IVB) injection with or without laser photocoagulation towards retinal nonperfusion area in ischemic CRVO. Therefore, 46 eyes of 46 treatment-naïve patients affected by ischemic CRVO were randomly selected and divided into two arms. The 22 patients in first group (IVB or group A) were treated with 3 consecutive monthly IVB and 24 individuals in the second group were administered IVB plus peripheral photocoagulation of nonperfused retina (group B or IVB+LASER). Further IVB injections were feasible if needed in both groups. All the patients were visited monthly for 9 months.


The differences of monthly checked BCVA adjusted for the BCVA at the base (month 0) were significantly higher in group B since the 4th to 8th month (p= 0.002 - 0.044 - 0.002 - 0.002 - 0.012). The differences of monthly checked central macular thickness (CMT) values adjusted for the base (month 0) was also significantly higher in both groups since the 1st to 9th month of study (all p<0.001). We disclosed a less frequent IVB injections among the participants in group B at the 4th, 6th, 7th, and 8th months (p=0.022, <0.001, 0.012, 0.038). The same trend was observed in consideration of all injections within the 9-month-period of survey between A and B groups respectively (5.83±1.95 vs. 4.05±1.09; p<0.001).


The photocoagulation of retinal nonperfused area in ischemic CRVO might amplify the advantageous therapeutic effects of IVB on BCVA as well as CMT and culminates in a dramatic diminution of IVB injection frequency.

Attachment: 47Powerpoint IRAVO.pptx

Last News

  - دومین ويژه نامه همايش بهاره چشم پزشكي منتشر شد
  -  شب بهاری چشم پزشکی با رحیم شهریاری
  - دومین همایش بهاره چشم پزشکی